JAK inhibitor treatment is not associated with stunted growth in children with common inflammatory diseases, according to a ...

Patients with eosinophilic granulomatosis with polyangiitis who received 2 years of treatment with the interleukin-5 ...

Policy swings have made it a slippery year for pharma ...

Rucaparib received FDA approval for BRCA-mutated mCRPC after prior androgen receptor–directed therapy, based on the TRITON3 trial results. The trial demonstrated significant improvement in ...

Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...

No increased risk for cancer was found among patients with RA receiving biologic or targeted synthetic DMARDs vs TNF inhibitors.

Abstract: Cardiovascular disease is a major life-threatening condition commonly monitored through electrocardiogram (ECG) signals. However, the ECG signals currently generated by sensors are often ...

To ensure Humira maintains its potency and effectiveness when you’re ready to inject it, you will need to keep it ...

AstraZeneca PLC is rated a Buy due to strong growth, prudent R&D reinvestment, low leverage and resilience. Learn more about ...

The FDA’s effort to curb high drug costs by accelerating approvals of cheaper medicines similar to expensive biologics will ...

Rheumatoid arthritis (RA) may cause hair loss due to medications, other autoimmune diseases, or stress. Learn about the ...

Piper Sandler 37th Annual Healthcare Conference December 3, 2025 8:30 AM ESTCompany ParticipantsDavid Amsellem - MD & Senior ...